Literature DB >> 1804379

Incidence survey of leukemia in China.

C Yang1, X Zhang.   

Abstract

A nationwide cooperative incidence survey of leukemia was carried out from 1986 to 1988 in a cooperative survey network covering 46 investigating areas. More than 60 million person-years were supervised and 1670 new cases identified. The annual incidence of leukemia was 2.76/10(5), and the 95% confidence interval of the population rate ranged from 2.63/10(5) to 2.89/10(5). The incidences in oil fields and polluted areas were significantly higher than those in other areas. The incidence of acute nonlymphocytic leukemia (ANLL) was 1.62/10(5); acute lymphocytic leukemia (ALL), 0.69/10(5); chronic myelocytic leukemia (CML), 0.36/10(5); chronic lymphocytic leukemia (CLL), 0.05/10(5); and special types, 0.03/10(5). The incidence and constituent ratio of CLL were significantly lower than those in Europe and America. A peak of ALL incidence before age 10 was seen; this rate then declined with increasing age until 30. However, the incidences of other leukemias rose with age, reaching peaks at old age (50-70). The leukemia rate in males was significantly higher than in females, both in youth (10-29) (caused by ALL) and at age old (mainly caused by ANLL). The incidences of ANLL subtypes (including M2b) are reported.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1804379

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  8 in total

1.  Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China.

Authors:  W Zheng; M S Linet; X O Shu; R P Pan; Y T Gao; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

2.  Exposures and cancer incidence near oil fields in the Amazon basin of Ecuador.

Authors:  M San Sebastián; B Armstrong; J A Córdoba; C Stephens
Journal:  Occup Environ Med       Date:  2001-08       Impact factor: 4.402

Review 3.  Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.

Authors:  Guang-Biao Zhou; Ji Zhang; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

Review 4.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

5.  Naringenin suppresses K562 human leukemia cell proliferation and ameliorates Adriamycin-induced oxidative damage in polymorphonuclear leukocytes.

Authors:  Rui-Fang Li; Ying-Qian Feng; Jun-Hui Chen; Lin-Tong Ge; Shu-Yuan Xiao; Xue-Lan Zuo
Journal:  Exp Ther Med       Date:  2015-01-16       Impact factor: 2.447

6.  Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia.

Authors:  Qian Sun; Li Wang; Hua-Yuan Zhu; Yi Miao; Wei Wu; Jin-Hua Liang; Lei Cao; Yi Xia; Jia-Zhu Wu; Yan Wang; Rong Wang; Lei Fan; Wei Xu; Jian-Yong Li
Journal:  Chin Med J (Engl)       Date:  2019-03-05       Impact factor: 2.628

7.  Cancer mortality and quantitative oil production in the Amazon region of Ecuador, 1990-2010.

Authors:  Suresh H Moolgavkar; Ellen T Chang; Heather Watson; Edmund C Lau
Journal:  Cancer Causes Control       Date:  2013-11-30       Impact factor: 2.506

8.  The pathological features of leukemic cells infiltrating the renal interstitium in chronic lymphocytic leukemia/small lymphocytic lymphoma from a large single Chinese center.

Authors:  Hui Wang; Xiaojuan Yu; Xu Zhang; Suxia Wang; Minghui Zhao
Journal:  Diagn Pathol       Date:  2021-07-04       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.